No black box warning on record for Mircera

As of the latest FDA labeling reviewed, Mircera (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA) does not carry a black box warning. Standard warnings and precautions still apply — see the full Mircera medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Hypertension: Control hypertension prior to initiating and during treatment with Mircera ( 5.3 ). • Seizures: Seizures have occurred in CKD patients participating in Mircera clinical studies. Increase monitoring of these patients for changes in seizure frequency or premonitory symptoms ( 5.4 ). • PRCA: If severe anemia and low reticulocyte count develop during Mircera

No black box warning on record for Mircera

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Hypertension: Control hypertension prior to initiating and during treatment with Mircera ( 5.3 ). • Seizures: Seizures have occurred in CKD patients participating in Mircera clinical studies. Increase monitoring of these patients for changes in seizure frequency or premonitory symptoms ( 5.4 ). • PRCA: If severe anemia and low reticulocyte count develop during Mircera

Mircera Black Box Warning

No black box warning on record for Mircera

Other warnings & precautions

Mircera Black Box Warning

No black box warning on record for Mircera

Other warnings & precautions